Shandong Weigao Group Medical Polymer Company Limited (01066.HK)

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 13,063 full-time employees. The company went IPO on 2004-02-27. The firm operates its businesses through six segments. The Medical Device Products segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The firm mainly operates its businesses in the domestic and overseas markets.